Diabetes Mellitus Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes Mellitus stocks.

Diabetes Mellitus Stocks Recent News

Date Stock Title
Oct 2 TNDM Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Oct 2 TNDM Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says
Oct 2 HALO High Growth Tech Stocks In The United States To Watch
Oct 2 DXCM Reasons to Retain DexCom Stock in Your Portfolio for Now
Oct 2 TNDM This pharma stock offers an attractive risk-reward says RBC
Oct 2 DXCM Down More Than 50%, Is DexCom Stock a Bargain Now?
Oct 1 TNDM BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
Oct 1 TNDM Why Tandem Diabetes Care Stock Took It on the Chin Tuesday
Oct 1 TNDM t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
Oct 1 HALO Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Oct 1 EVOK Evoke Pharma announces proceeds from existing warrants and board expansion
Oct 1 EVOK Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
Oct 1 PODD Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
Sep 30 DXCM 2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
Sep 30 PODD Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
Sep 29 GPCR Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?
Sep 27 PODD Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years
Sep 26 DXCM Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
Diabetes Mellitus

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags